Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 7,497Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Myfembree/Ryeqo

02 3Orgovyx

PharmaCompass

01

Brand Name : Orgovyx

Relugolix

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Orgovyx

arrow
euroPLX 86 Munich
Not Confirmed

Relugolix

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 51

2020 Revenue in Millions : 0

Growth (%) : 100

blank

02

Brand Name : Myfembree/Ryeqo

Relugolix

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Myfembree/Ryeqo

arrow
euroPLX 86 Munich
Not Confirmed

Relugolix

Main Therapeutic Indication : Women's Healthcare

Currency : USD

2021 Revenue in Millions : 8

2020 Revenue in Millions : 0

Growth (%) : New Launch in 2021

blank

03

Brand Name : Myfembree/Ryeqo

Relugolix

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Myfembree/Ryeqo

arrow
euroPLX 86 Munich
Not Confirmed

Relugolix

Main Therapeutic Indication : Women's Health

Currency : USD

2022 Revenue in Millions : 25

2021 Revenue in Millions : 8

Growth (%) : 234

blank

04

Brand Name : Orgovyx

Relugolix

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Orgovyx

arrow
euroPLX 86 Munich
Not Confirmed

Relugolix

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 160

2021 Revenue in Millions : 51

Growth (%) : 216

blank

05

Brand Name : Orgovyx

Relugolix

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Orgovyx

arrow
euroPLX 86 Munich
Not Confirmed

Relugolix

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 262

2022 Revenue in Millions : 160

Growth (%) : 86

blank

06

Brand Name : Myfembree/Ryeqo

Relugolix

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Myfembree/Ryeqo

arrow
euroPLX 86 Munich
Not Confirmed

Relugolix

Main Therapeutic Indication : Women's Health

Currency : USD

2023 Revenue in Millions : 60

2022 Revenue in Millions : 32

Growth (%) : 110

blank